Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial Infarction
Article Abstract:
Heart attack patients who are admitted to a hospital should receive angioplasty within two hours of admission. Angioplasty is a technique to open blocked coronary arteries, which is the cause of most heart attacks. In a study of 27,080 heart attack patients admitted to 661 US hospitals between 1994 and 1998, those who waited longer than two hours for angioplasty had 41% to 62% higher mortality rates than those treated within two hours. About half the patients had to wait longer than two hours for angioplasty.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE quality improvement initiative
Article Abstract:
The use and predictors of early invasive management strategies in high-risk patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS) is determined and the association of early invasive management with mortality is examined. It is found out that an early invasive management strategy is not utilized in the majority of high-risk patients with NSTE ACS.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: The PCI-CLARITY Study
Article Abstract:
A study investigates if clopidogrel pretreatment before percutaneous coronary intervention (PCI) in patients with recent ST-segment elevation myocardial infarction (STEMI) is superior to clopidogrel treatment initiated at the time of PCI in preventing major adverse cardiovascular events. Clopidogrel pretreatment is found to significantly reduce the incidence of cardiovascular death or ischemic complications both before and after PCI and without a significant increase in major or minor bleeding.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project
- Abstracts: Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis
- Abstracts: Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein
- Abstracts: Validation of dietary intakes of protein and energy against 24 hour urinary N and DLW energy expenditure in middle-aged women, retired men and post-obese subjects; comparisons with validation against presumed energy requirements
- Abstracts: Relation Between Hospital Primary Angioplasty Volume and Mortality for Patients With Acute MI Treated With Primary Angioplasty vs Thrombolytic Therapy